Compugen Ltd. (CGEN)
2.13
+0.17
(+8.67%)
USD |
NASDAQ |
Nov 09, 16:00
2.13
0.00 (0.00%)
After-Hours: 19:48
Compugen Enterprise Value : 63.38M for Nov. 6, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 06, 2026 | 63.38M |
| November 05, 2026 | 59.59M |
| November 04, 2026 | 70.01M |
| November 03, 2026 | 68.12M |
| November 02, 2026 | 65.28M |
| October 30, 2026 | 65.28M |
| October 29, 2026 | 70.96M |
| October 28, 2026 | 68.12M |
| October 27, 2026 | 64.33M |
| October 26, 2026 | 55.33M |
| October 23, 2026 | 61.49M |
| October 22, 2026 | 63.38M |
| October 21, 2026 | 78.54M |
| October 20, 2026 | 80.43M |
| October 19, 2026 | 64.33M |
| October 16, 2026 | 63.38M |
| October 15, 2026 | 74.75M |
| October 14, 2026 | 67.17M |
| October 13, 2026 | 65.28M |
| October 12, 2026 | 73.80M |
| October 09, 2026 | 79.49M |
| October 08, 2026 | 78.54M |
| October 07, 2026 | 81.38M |
| October 06, 2026 | 88.01M |
| October 05, 2026 | 96.54M |
| Date | Value |
|---|---|
| October 02, 2026 | 96.54M |
| October 01, 2026 | 99.38M |
| September 30, 2026 | 103.17M |
| September 29, 2026 | 100.32M |
| September 28, 2026 | 98.43M |
| September 25, 2026 | 103.17M |
| September 24, 2026 | 102.22M |
| September 23, 2026 | 99.38M |
| September 22, 2026 | 113.59M |
| September 21, 2026 | 108.38M |
| September 18, 2026 | 113.59M |
| September 17, 2026 | 110.74M |
| September 16, 2026 | 106.01M |
| September 15, 2026 | 106.01M |
| September 14, 2026 | 112.64M |
| September 11, 2026 | 111.69M |
| September 10, 2026 | 110.74M |
| September 09, 2026 | 112.64M |
| September 08, 2026 | 120.22M |
| September 04, 2026 | 123.06M |
| September 03, 2026 | 119.74M |
| September 02, 2026 | 126.85M |
| September 01, 2026 | 123.06M |
| August 31, 2026 | 120.22M |
| August 28, 2026 | 124.01M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Pluri, Inc. | 46.05M |
| Evogene Ltd. | 5.476M |
| Scinai Immunotherapeutics Ltd. | 7.709M |
| CollPlant Biotechnologies Ltd. | 5.443M |
| Regentis Biomaterials Ltd. | 50.73M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -7.006M |
| Revenue (Quarterly) | 2.602M |
| Total Expenses (Quarterly) | 9.608M |
| EPS Diluted (Quarterly) | -0.074 |
| Gross Profit Margin (Quarterly) | -3.54% |
| Profit Margin (Quarterly) | -269.3% |
| Earnings Yield | 17.39% |
| Operating Earnings Yield | 15.07% |
| Normalized Earnings Yield | 17.39 |